Please login to the form below

Not currently logged in
Email:
Password:

The Prime Medical Group strengthens leadership team

Karen Turner and Gauri Saal join the comms agency

The Prime Medical Group Karen TurnerGlobal communications agency The Prime Medical Group has appointed Karen Turner as vice president of client services and Gauri Saal as principal medical writer in its Knutsford, UK office.

Turner (pictured) has over 20 years of medical communications experience, and will be responsible for providing divisional leadership across key accounts in both the agency's UK and US offices.

She joins The Prime Medical Group from Watermeadow Medical, part of Ashfield Healthcare Communications, where she most recently served as a business unit director.

Prior to this, Turner worked at Gardiner-Caldwell Communications as a senior account director, having first joined the firm in 1995.

Meanwhile, Saal moves to the agency's health economics and outcomes research (HEOR) team and also holds a research officer-ship at Swansea Centre for Health Economics at Swansea University.

Saal brings expertise in developing market access and reimbursement strategies and stakeholder-targeted HEOR communications to the role.

Graeme Peterson, The Prime Medical Group's founder and chief executive officer, said: “We're delighted to welcome Karen and Gauri to The Prime Medical Group and I'm very excited about the fantastic expertise they bring to what is already a very strong, industry-leading team.

“The Group has continued to grow in 2016 and both Karen and Gauri's expertise will be utilised to support recent key new account wins, working with leading pharmaceutical companies.”

16th September 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics